Medicine Prize Research Articles

The Nobel Prize in Physiology or Medicine 2023 was awarded for discoveries concerning base modifications that enabled the development of effective mRNA vaccines against COVID-19

N/A

TR(i)P Goes On: Auxiliary TRP Channel Subunits?

Transient receptor potential (TRP) cation channels are a diverse family of channels whose members play prominent roles as cellular sensors and effectors. The important role of TRP channels (and mechanosensitive piezo channels) in the complex interaction of our senses with the environment was underlined by the award of the Nobel Prize in Physiology or Medicine to 2 pioneers in this field, David Julius and Ardem Patapoutian. There are many competent and comprehensive reviews on many aspects of the TRP channels, and there is no intention to expand on them. Rather, after an introduction to the nomenclature, the molecular architecture of native TRP channel/protein complexes in vivo will be summarized using TRP channels of the canonical transient receptor potential subfamily as an example. This molecular architecture provides the basis for the signatures of native canonical transient receptor potential currents and their control by endogenous modulators and potential drugs.

Celebrating vaccines: The 2023 Nobel prize in medicine or physiology

Celebrating vaccines: The 2023 Nobel prize in medicine or physiology

Nobel Prize in physiology or medicine 2023: Development of mRNA therapeutics that paved the path of formulation of COVID-19 vaccine

Since the concept of the vaccine was developed by Edward Jenner in 1796, vaccinology has traveled a long way with gradual improvement toward developing better methods of formulation of vaccines. In this premises in the 1990s, Karikó and Weissman joined their hands and minds aiming at understanding how different RNA species interact with the immune system. During their long journey in this direction, they performed extensive studies involving well-conceived molecular biology-based experiments that resulted in a breakthrough discovery relating to RNA therapeutics in general and messenger RNA (mRNA) therapeutics in particular. In this endeavor, they developed mRNA technology that actually paved the path leading to the development of mRNA vaccine that has many advantages. In December 2019, when the deadly virus SARS-CoV-2 emerged, which, in no time, caused a pandemic as well as an epidemic, thereby throwing a fierce challenge to the total healthcare systems worldwide, it was possible to take care of that challenge through the formulation and manufacturing on a large scale the mRNA vaccine against SARS-CoV-2 using the above technology. Thus, mRNA technology has created a strong platform that has spelled out a great promise toward controlling any pathogen infection and saving human life through the development of mRNA vaccine at a quick pace. In this short review, an attempt will be made to highlight the contributions of Karikó and Weissman and how they led the formulation of a vaccine against COVID-19, which fetched them the Nobel Prize in Medicine or Physiology, 2023.

Therapeutic Monoclonal Antibodies Approved by FDA in 2023

Compared with the annual record high, 17 therapeutic monoclonal antibodies (mAb) approved in 2017, this year new record was set, total 20 therapeutic mAb were approved by FDA, interestingly 4 of them are bispecific engager, Ag + CD3, Which significantly increases the efficacy. Monoclonal antibody technique was created by Georges Köhler, César Milstein, and Niels Kaj Jerne in 1975 by using a mouse x mouse hybridoma. In 1984 they were awarded the Nobel Prize in Medicine for the discovery

The Nobel family

Nobel laureates cluster together. 696 of the 727 winners of the Nobel Prize in physics, chemistry, medicine, and economics belong to one single academic family tree. 668 trace their ancestry to Emmanuel Stupanus, 228 to Lord Rayleigh (physics, 1904). Craig Mello (medicine, 2006) counts 51 Nobelists among his ancestors. Chemistry laureates have the most Nobel ancestors and descendants, economics laureates the fewest. Chemistry is the central discipline. Its Nobelists have trained and are trained by Nobelists in other fields. Nobelists in physics (medicine) have trained (by) others. Economics stands apart. Openness to other disciplines is the same in recent and earlier times. The familial concentration of Nobelists is lower now than it used to be.

Disparities in funding for Nobel Prize awards in medicine and physiology across nationalities, races, and gender.

Since 1901, the Nobel Prize in Physiology and Medicine has been awarded to numerous individuals for their outstanding contributions. This article presents a comprehensive analysis of the Nobel Prize recipients, focusing on gender, race, and nationality. We observe that an alarming disparity emerges when we examine the underrepresentation of Black scientists among Nobel laureates. Furthermore, trends in nationalities show how Americans make up the majority of Nobel Prize winners, while there is a noticeable lack of gender and racial minority winners of the Nobel Prize in Physiology and Medicine. Together, this highlights the importance of diversity and inclusion in scientific achievement. We offer suggestions and techniques, including funding opportunities and expanding nominators, to improve the gender, racial, and geographical diversity of Nobel Prizes.

70th Anniversary of Folia Biologica.

Folia Biologica celebrates 70 years of continuous publication of research papers. The first volume was published in Prague in 1954 on behalf of the Institute of Molecular Genetics of the Czechoslovak Academy of Sciences (since 1990 the Academy of Sciences of the Czech Republic) under the subtitle "International edition of the journal Czechoslovakian Biology". Born in the dark days of the Cold War, Folia Biologica provided a thin but important link between the politically controlled science behind the Iron Curtain in the former Czechoslovakia and that of the free Western world. Initially, the journal focused on research papers in the fields of experimental medicine, immunology, virology, and experimental zoology. Since 1961 (Volume 7), Folia Biologica has been indexed in the Web of Science database. The first issue of Volume 7 was introduced by a review article by Peter Brian Medawar (1915-1987), winner of the 1960 Nobel Prize in Physiology or Medicine "for the discovery of acquired immunological tolerance", which is reprinted in this anniversary issue [1].In the late 1960s, during the political relaxation that culminated in the Prague Spring, cooperation with free Western science intensified and enabled a lively scientific dialogue between Czechoslovak and foreign biological scientists, namely immunologists, molecular biologists, and virologists, as illustrated by a series of original research articles from Folia Biologica by Georg Davis Snell (1903-1996) and Jean Dausset (1916-2009), who were awarded the Nobel Prize in Physiology and Medicine in 1980 "for their discoveries concerning genetically determined structures on the cell surface that regulate immunological reactions", which led to the discovery of the major histocompatibility system (MHC) [2-7]. Another powerful example is an article in Folia Biologica by François Jacob (1920-2013), who was awarded the Nobel Prize in 1965 for discoveries that helped elucidate the transcriptional control of enzyme levels [8].Despite the years of political repression during the "normalization" period following the invasion of the Warsaw Pact troops into Czechoslovakia in 1968, the scientists and editors of Folia Biologica from the Academy of Sciences were able to maintain vibrant contacts with the world's leading scientists. In 1981, the journal changed its subtitle to "Journal of Cellular and Molecular Biology". In 1983, Folia Biologica published the article by Renato Dulbecco (1914-2012), who was awarded the Nobel Prize in 1975 for "discoveries concerning the interaction between tumor viruses and the genetic material of the cell"[9].With further orientation towards human molecular medicine, the journal entered the era after the Velvet Revolution in 1989, which represented the desired end of political control over national science. The interest of Czechoslovak and Czech scientists in publishing in Folia Biologica began to decline at the end of the 1990s, when they had at their disposal the full range of scientific journals from all over the world. Since volume 63 (January 2006), Folia Biologica has been published by the First Faculty of Medicine, Charles University, Prague, in a fully open access model.With the new decade that begins with this issue, the journal has undergone a series of improvements, including the strengthening of the editorial board, the assignment of a DOI (Digital Object Identifier) number to each article, the improvement of the cover layout and graphics, the innovation of the website, and a more precise definition of the journal's aim. Folia Biologica now publishes articles describing original research aimed at elucidating a wide range of issues in biomedicine, especially in oncology and human molecular genetics. In addition, the journal focuses on the cellular and molecular mechanisms of disease and provides studies on all organisms, cells and tissues that serve as biological and disease models, as well as clinical and translational research studies. Further improvements towards sustainable and rapid publication will be accomplished by introducing an online-only publication model planned for 2025.To celebrate the 70th anniversary of Folia Biologica, we begin the anniversary volume with the reprint of Sir Peter Brian Medawar's review. To commemorate the continuing history of the journal, and to thank our predecessors and contributors, we present the title pages, table of contents, and editorial boards of Folia Biologica by decade, illustrating the changes in research focus, human knowledge, and the evolution of the journal.We would like to thank all authors, reviewers, editorial board members, editors and managing editors involved in the journal production in the past decades, namely Ivan Málek, Milan Hašek, Alena Langerová, Josef Říman, Jan Bubeník, Jan Svoboda, Emanual Nečas, Karel Smetana Jr. and Zdeněk Kostrouch, for their commitment and dedication to Folia Biologica.We wish our journal many more decades of scientifically interesting articles, publishing open-minded science by excellent authors for the pleasure of satisfied readers!

ВИНАХІД КОМП‘ЮТЕРНОЇ ТОМОГРАФІЇ І ЙОГО ЗНАЧЕННЯ В ІСТОРІЇ ПУЛЬМОНОЛОГІЇ

Imaging diagnostic methods in pulmonology originate from the discovery of X-rays. Radiography is the first-line tool for chest imaging, but in many cases its capabilities are limited. The aim was to study the history of the invention of computed tomography. Since the radiogram is a two-dimensional summation image of a three-dimensional anatomical structure, there was a need to visualize separate layers of the pathological process. Since 1913, many technical solutions of tomography have been tested. Linear tomography for some time served for the diagnosis of lung pathology, helped to determine the localization more accurately, examine a prevalence, nature and structure of the pathological process, to detect small pathological formations and cavities. But the quality of tomography was not satisfactory. The two outstanding inventors of computed tomography who were awarded the 1979 Nobel Prize in Medicine were not the physicians. Allan McLeod Cormack (Professor and Head of the Institute of Physics at Tufts University, Medford, Massachusetts, USA) was the first to outline the principles of cross-sectional tissue reconstruction in an organ based on X-ray projections in 1963. Godfrey Newbold Hounsfield (Head of Medical Research at Electric and Musical Industries, Middlesex, England) not only reproduced the mathematical algorithms of the technique, but also designed the tomograph and directly participated in its clinical implementation in 1971. Among the developers of the idea of three-dimensional X-ray tomography in 19571958 were the scientists of Kyiv Polytechnic Institute Semyon Tetelbaum and Boris Korenblyum. Key words: radiology, computed tomography, history of pulmonology.

Roles of TRP and PIEZO receptors in autoimmune diseases.

Autoimmune diseases are pathological autoimmune reactions in the body caused by various factors, which can lead to tissue damage and organ dysfunction. They can be divided into organ-specific and systemic autoimmune diseases. These diseases usually involve various body systems, including the blood, muscles, bones, joints and soft tissues. The transient receptor potential (TRP) and PIEZO receptors, which resulted in David Julius and Ardem Patapoutian winning the Nobel Prize in Physiology or Medicine in 2021, attracted people's attention. Most current studies on TRP and PIEZO receptors in autoimmune diseases have been carried out on animal model, only few clinical studies have been conducted. Therefore, this study aimed to review existing studies on TRP and PIEZO to understand the roles of these receptors in autoimmune diseases, which may help elucidate novel treatment strategies.

Sleeping Beauty 2000: an evaluation index of leading and original literature based on the Nobel Prize in Physiology or Medicine

Sleeping Beauty 2000: an evaluation index of leading and original literature based on the Nobel Prize in Physiology or Medicine

"All for One and One for All": The Secreted Heat Shock Protein gp96-Ig Based Vaccines.

It has been 50 years since Peter Charles Doherty and Rolf M Zinkernagel proposed the principle of "simultaneous dual recognition", according to which adaptive immune cells recognized "self" and "non-self" simultaneously to establish immunological efficacy. These two scientists shared the 1996 Nobel Prize in Physiology or Medicine for this discovery. Their basic immunological principle became the foundation for the development of numerous vaccine approaches against infectious diseases and tumors, including promising strategies grounded on the use of recombinant gp96-Ig developed by our lab over the last two decades. In this review, we will highlight three major principles of the gp96-Ig vaccine strategy: (1) presentation of pathogenic antigens to T cells (specificity); (2) activation of innate immune responses (adjuvanticity); (3) priming of T cells to home to the epithelial compartments (mucosal immunity). In summary, we provide a paradigm for a vaccine approach that can be rapidly engineered and customized for any future pathogens that require induction of effective tissue-resident memory responses in epithelial tissues.

Charles Brenton Huggins: A historical review of the Nobel laureate's pioneering discoveries.

Androgen deprivation therapy for prostate cancer was pioneered by Charles Huggins, laureate of the Nobel Prize in Medicine in 1966. The authors tried to understand the scientific context and how previous findings paved Huggins way to his discoveries. With the help of summary or review articles on androgen deprivation therapy, the authors identified key publications and used his Nobel Prize speech as a basis to understand his discoveries. Furthermore, they used a recording of the laboratory-talk interview he gave about his findings to guide them to relevant publications. The authors found that the basis for Huggins' discoveries was the isolation of testosterone in 1935, not long before Huggins' 1941 hallmark publication. Huggins' work follows major experiments in the 19th century in orchiectomy done as a treatment for prostate hypertrophy. Researching the etiology of idiopathic hydrocele, Huggins analyzed the composition of prostate fluid. Further research led to the discovery of the influence of castration, testosterone, and estrogen on acid phosphatase. Recently developed methods facilitated the measurement of the phosphatases. He, therefore, had a biomarker for metastatic prostate cancer to measure treatment response. Very early on, he reported clinical improvements after castration in metastatic patients. Although the effect of orchiectomy on prostate hypertrophy was already known, Huggins was the first to show that testosterone stimulated and estrogen decreased the activity of prostate cancer. Huggins also established phosphatases as a tumor marker to measure disease response.

CREATIVITY AND ORIGINALITY ARE KEY ELEMENTS IN MEDICAL RESEARCH: RECENT ILLUSTRATION BY THE 2023 NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE TO KATALIN KARIKO AND DREW WEISSMAN

For at least a century, an often-debated topic is what is of primary importance to make breakthrough in biomedical research: originality/creativity or sophisticated methods/equipment. We present here a short historical overview arguing about the importance of creativity, originality, and persistence. Namely, the best living example of this is the 2023 Nobel Prize in Physiology or Medicine awarded to Drs. Katalin Kariko and Drew Weissman for the invention and development of mRNA-based vaccine against COVID-19. Katalin Kariko had a life-long obsession to use mRNA for cancer therapy, but when the structure of SARS-CoV-2 was announced, she shifted her interest to develop an mRNA-based vaccine against the new virus. But since the mRNA molecule is notoriously unstable and easily degraded if injected intracellularly, she teamed up with Dr. Weissman who was working on techniques to deliver mRNA molecules intracellularly. This creative teamwork with original ideas of vaccine development illustrates what other creative scientists, like Alexander Flemming, Hans Selye, Leon Popielski and James Black discovered in their fields. The sad part of the story is that only two of these scientists got the Nobel Prize.

Neurosciences and Nobel Prizes in Medicine and Physiology, A Brief Historical Sketch

In order to stimulate and promote the development of humanity, Alfred Bernhard Nobel, in his will, established with his fortune a fund with which the best exponents in Literature, Physiology or Medicine, Physics, Chemistry and Peace would be rewarded. Over the years, awardees have come from various fields related to physiology and medicine. This review was motivated by the large number of Nobel Prize winners in Medicine and Physiology in the neuroscientific field. Despite there being numerous publications about this award, there are few that specifically deal with neuroscience, so it was decided to briefly describe it. the Nobel Prizes that were awarded to this branch of medicine, highlighting those that were considered most important by the authors and mentioning the others.

The pivotal role of uridine modifications in the development of mRNA technology

In 2023, Katalin Karikó and Drew Weissman were awarded the Nobel Prize in Physiology or Medicine for their nucleoside base modifications research that later enabled mRNA vaccine development against COVID-19. This paper briefly reviews these achievements in the context of the development of mRNA technology and its enormous potential for medicine in the prevention of various infectious diseases and cancer treatment, including personalised therapies. Without a doubt, Karikó and Weissman's discoveries were vital in getting around one of the biggest problems with using mRNA molecules in real life: they had to be recognised by endosomal Toll-like receptors and the innate immune response that came after, causing exogenous mRNA molecules to have less translational activity and break down.. Although the Nobel Prize for Karikó and Weissman is fully justified, it must be stressed that mRNA technology would never unfold its potential for public health without a collective scientific effort encompassing over 40 years of research.

The key to practical application of mRNA technology: A brief analysis of the 2023 Nobel Prize in Physiology or Medicine

The key to practical application of mRNA technology: A brief analysis of the 2023 Nobel Prize in Physiology or Medicine

EDITORIAL. El Premio Nobel de Medicina o Fisiología 2023

The 2023 Nobel Prize in Medicine or Physiology, awarded to Katalin Karikó and Drew Weissman, recognizes the fundamental discovery that the modification of bases in mRNA synthesized in vitro prevents inflammatory responses and increases protein production when it is introduced into the cell. Although these discoveries received little attention when they were published between 2005 and 2010, ten years later they made possible the rapid develop-ment of vaccines against COVID-19

Tributaries of the 2023 Nobel Prize in Physiology or Medicine, and lessons learned.

Almost without exception, scientific breakthroughs are not epistemological orphans. Historians of science have developed a body of scholarship on this, and the cases arising in our era continue to confirm the phenomenon. The work by Katalin Karikó and Drew Weissman that proved foundational for the subsequent development of mRNA vaccines for COVID-19 had its antecedent roots yet is also a striking example of both serendipity and their persistence. Their receipt of the 2023 Nobel Prize in Physiology or Medicine was greatly deserved and, as Alfred Nobel likely envisioned the broad impact to be for all the prizes, affirms to the public at large that there is such a thing as the scientific method, and that there are such things as facts. The importance of society recognizing this has always been critically important, perhaps never more so than now.

The Nobel Prize for Medicine was Awarded to Scientists from Hungary and The USA for the Study of RNA

.